NRIP1 and B-cell chronic lymphocytic leukemia: NRIP1 is a regulator of oncogenic signaling pathways in chronic lymphocytic leukemia and a therapeutic target to sensitize acute myeloid leukemia to all-trans retinoic acid28,29.